For an AI-powered solution to accelerate diagnosis and treatment for neurovascular diseases, Viz.ai provides a comprehensive care coordination platform. The platform uses FDA-cleared algorithms to analyze medical imaging data, offering real-time insights and automated assessments to accelerate diagnosis and treatment. Focused on neurovascular disease, cardiovascular needs and vascular medicine, Viz.ai is used by more than 1,400 hospitals to improve patient outcomes and streamline care workflows.
Another top contender is RapidAI, a clinically grounded AI platform designed to improve patient outcomes in neurovascular and vascular care. The platform empowers care teams to make more informed decisions faster, getting patients to treatment sooner and improving care overall. RapidAI has a range of products addressing specific clinical needs in stroke, aneurysm and pulmonary embolism, and offers features such as fast turnaround times, accurate diagnoses and streamlined workflows.